Success Metrics

Clinical Success Rate
95.6%

Based on 65 completed trials

Completion Rate
96%(65/68)
Active Trials
5(6%)
Results Posted
22%(14 trials)
Terminated
3(4%)

Phase Distribution

Ph not_applicable
5
6%
Ph phase_1
42
50%
Ph phase_2
4
5%
Ph phase_3
9
11%
Ph phase_4
21
25%

Phase Distribution

42

Early Stage

4

Mid Stage

30

Late Stage

Phase Distribution81 total trials
Phase 1Safety & dosage
42(51.9%)
Phase 2Efficacy & side effects
4(4.9%)
Phase 3Large-scale testing
9(11.1%)
Phase 4Post-market surveillance
21(25.9%)
N/ANon-phased studies
5(6.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

65 of 70 finished

Non-Completion Rate

7.1%

5 ended early

Currently Active

5

trials recruiting

Total Trials

84

all time

Status Distribution
Active(5)
Completed(65)
Terminated(5)
Other(9)

Detailed Status

Completed65
unknown9
Recruiting4
Terminated3
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
84
Active
5
Success Rate
95.6%
Most Advanced
Phase 4

Trials by Phase

Phase 142 (51.9%)
Phase 24 (4.9%)
Phase 39 (11.1%)
Phase 421 (25.9%)
N/A5 (6.2%)

Trials by Status

terminated34%
completed6577%
unknown911%
active_not_recruiting11%
recruiting45%
withdrawn22%

Recent Activity

Clinical Trials (84)

Showing 20 of 84 trialsScroll for more
NCT07597928Phase 1

A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

Completed
NCT06899061Phase 1

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Active Not Recruiting
NCT07838987Phase 1

A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)

Completed
NCT07797478Phase 1

A Study of RO7890597 in Healthy Adult Volunteers

Recruiting
NCT01136317Phase 2

Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects

Completed
NCT06916143Phase 1

Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid

Terminated
NCT07284173Phase 1

A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.

Completed
NCT05407675Phase 1

A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors

Completed
NCT07329972Phase 1

A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants

Completed
NCT07141381Phase 1

A Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755

Completed
NCT07471867Phase 4

Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention

Recruiting
NCT07122024Phase 4

Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment

Recruiting
NCT06417229Phase 1

Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants

Completed
NCT02475161Phase 1

A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants

Completed
NCT05899829Phase 1

Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant

Completed
NCT06054464Phase 1

A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants

Completed
NCT05918822Phase 1

A Study of Maribavir Pediatric Formulation in Healthy Adult Participants

Completed
NCT06264440Phase 1

A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants

Completed
NCT03320538Not Applicable

Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases

Completed
NCT03237741Phase 1

Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants

Completed

Drug Details

Intervention Type
DRUG
Total Trials
84